Baker Ellis Asset Management LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 964 filers reported holding BAXTER INTL INC in Q2 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Baker Ellis Asset Management LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2020$129,000
+5.7%
1,5000.0%0.04%
-13.6%
Q1 2020$122,000
-2.4%
1,5000.0%0.04%
+25.7%
Q4 2019$125,000
-12.0%
1,500
-7.7%
0.04%
-7.9%
Q3 2019$142,000
+6.8%
1,6250.0%0.04%
+8.6%
Q2 2019$133,000
+9.0%
1,625
+8.3%
0.04%
+2.9%
Q1 2019$122,000
+5.2%
1,5000.0%0.03%
+13.3%
Q3 2018$116,000
+4.5%
1,5000.0%0.03%
+3.4%
Q2 2018$111,000
+1.8%
1,500
-16.7%
0.03%
-3.3%
Q2 2017$109,000
-13.5%
1,8000.0%0.03%
-28.6%
Q2 2015$126,000
-28.0%
1,800
-29.4%
0.04%
-25.0%
Q1 2015$175,000
-10.3%
2,550
-4.0%
0.06%
-13.8%
Q4 2014$195,000
+10.8%
2,655
+8.1%
0.06%
+6.6%
Q3 2014$176,000
-0.6%
2,4550.0%0.06%
+1.7%
Q2 2014$177,000
-28.0%
2,455
-26.7%
0.06%
-29.4%
Q1 2014$246,000
+12.3%
3,350
+6.3%
0.08%
+11.8%
Q4 2013$219,000
+19.0%
3,150
+12.5%
0.08%
+10.1%
Q3 2013$184,000
+47.2%
2,800
+55.6%
0.07%
+38.0%
Q2 2013$125,0001,8000.05%
Other shareholders
BAXTER INTL INC shareholders Q2 2017
NameSharesValueWeighting ↓
Third Point 41,000,000$2,482,140,00022.00%
THUNDERBIRD PARTNERS LLP 1,711,643$103,623,00012.17%
SECTOR GAMMA AS 1,070,333$64,798,0009.42%
Veritas Asset Management LLP 10,179,102$616,243,0004.81%
13D Management LLC 194,807$11,794,0004.18%
Progressive Investment Management Corp 78,316$4,741,0003.69%
Aristotle Capital Management, LLC 6,846,307$414,476,0003.46%
ARGENT CAPITAL MANAGEMENT LLC 1,394,075$84,397,0003.37%
Lipe & Dalton 80,073$4,848,0003.14%
PURA VIDA INVESTMENTS, LLC 125,000$7,568,0003.00%
View complete list of BAXTER INTL INC shareholders